TY  - CONF

T1  - Clinically meaningful responses achieved with tralokinumab in adults with moderate-to-severe atopic dermatitis who did not meet IGA 0/1 at initial 16-week treatment

JO  - JOURNAL OF INVESTIGATIVE DERMATOLOGY

PY  - 2022/01/01

AU  - Simpson E

AU  - Blauvelt A

AU  - Silverberg JI

AU  - Cork M

AU  - Katoh N

AU  - Mark T

AU  - Schneider S

AU  - Wollenberg A

ED  - 

VL  - 142

IS  - 8

SP  - B17

EP  - B17

Y2  - 2024/12/22

ER  -